Use of predictive markers to improve cardiovascular protection

Area of Science:

• Cardiology
• Hypertension Management
• Preventive Medicine

Background:

• Hypertension is a major contributor to global cardiovascular morbidity and mortality.
• Traditional assessment of antihypertensive therapies relies on major 'hard' cardiovascular events.
• The long natural history of hypertension necessitates alternative monitoring strategies.

Purpose of the Study:

• To highlight the utility of monitoring intermediate end points in hypertension management.
• To propose a strategy for improved individual risk stratification.
• To evaluate the effectiveness of antihypertensive treatments in modifying target organ damage.

Main Methods:

• Focus on measurable 'intermediate' end points or 'disease markers'.
• Utilize these markers for patient prognosis assessment.
• Employ this strategy for evaluating antihypertensive treatment efficacy over time.

Main Results:

• Intermediate end points provide more accurate individual risk stratification.
• Monitoring disease markers allows for better evaluation of treatment efficacy.
• This approach facilitates assessment of target organ damage progression.

Conclusions:

• Monitoring intermediate end points is a valuable and affordable clinical strategy for hypertension.
• It enables effective evaluation of patient prognosis and treatment effectiveness.
• This method aids in preventing or modifying the course of target organ damage.